1
/
of
0
FDA Drug Approval, N215133, SERTRALINE HYDROCHLORIDE
FDA Drug Approval, N215133, SERTRALINE HYDROCHLORIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 215133
Company: ALMATICA
Drug Name: SERTRALINE HYDROCHLORIDE
Active Ingredients: SERTRALINE HYDROCHLORIDE
Strength: EQ 200MG BASE
Dosage Form/Route: CAPSULE;ORAL
Action Date: 10/04/2021
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: ALMATICA
Drug Name: SERTRALINE HYDROCHLORIDE
Active Ingredients: SERTRALINE HYDROCHLORIDE
Strength: EQ 200MG BASE
Dosage Form/Route: CAPSULE;ORAL
Action Date: 10/04/2021
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details